Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Integrated analysis of 10 lymphoma datasets identifies E2F8 as a key regulator in Burkitt's lymphoma and mantle cell lymphoma.

Yang AP, Liu LG, Chen MM, Liu F, You H, Liu L, Yang H, Xun Y, Liu J, Wang RX, Brand DD, Liu D, Zheng SG, Li WX.

Am J Transl Res. 2019 Jul 15;11(7):4382-4396. eCollection 2019.

2.

Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications.

Yang S, Wang J, Brand DD, Zheng SG.

Front Immunol. 2018 Apr 19;9:784. doi: 10.3389/fimmu.2018.00784. eCollection 2018. Review.

3.

The role of Syk in peripheral T cells.

Park JE, Majumdar S, Brand DD, Rosloniec EF, Yi AK, Stuart JM, Kang AH, Myers LK.

Clin Immunol. 2018 Jul;192:50-57. doi: 10.1016/j.clim.2018.04.007. Epub 2018 Apr 16.

4.

mPGES1-Dependent Prostaglandin E2 (PGE2) Controls Antigen-Specific Th17 and Th1 Responses by Regulating T Autocrine and Paracrine PGE2 Production.

Maseda D, Johnson EM, Nyhoff LE, Baron B, Kojima F, Wilhelm AJ, Ward MR, Woodward JG, Brand DD, Crofford LJ.

J Immunol. 2018 Jan 15;200(2):725-736. doi: 10.4049/jimmunol.1601808. Epub 2017 Dec 13.

5.

In Vivo Attenuation of Antibody-Mediated Acute Renal Allograft Rejection by Ex Vivo TGF-β-Induced CD4+Foxp3+ Regulatory T Cells.

Liao T, Xue Y, Zhao D, Li S, Liu M, Chen J, Brand DD, Zheng H, Zhang Y, Zheng SG, Sun Q.

Front Immunol. 2017 Oct 16;8:1334. doi: 10.3389/fimmu.2017.01334. eCollection 2017.

6.

The Role of Leukocyte-Associated Ig-like Receptor-1 in Suppressing Collagen-Induced Arthritis.

Kim S, Easterling ER, Price LC, Smith SL, Coligan JE, Park JE, Brand DD, Rosloniec EF, Stuart JM, Kang AH, Myers LK.

J Immunol. 2017 Oct 15;199(8):2692-2700. doi: 10.4049/jimmunol.1700271. Epub 2017 Sep 8.

7.

Monomeric, porous type II collagen scaffolds promote chondrogenic differentiation of human bone marrow mesenchymal stem cells in vitro.

Tamaddon M, Burrows M, Ferreira SA, Dazzi F, Apperley JF, Bradshaw A, Brand DD, Czernuszka J, Gentleman E.

Sci Rep. 2017 Mar 3;7:43519. doi: 10.1038/srep43519.

8.

Characterization of the Syk-Dependent T Cell Signaling Response to an Altered Peptide.

Park JE, Rotondo JA, Cullins DL, Brand DD, Yi AK, Stuart JM, Kang AH, Myers LK.

J Immunol. 2016 Dec 15;197(12):4569-4575. Epub 2016 Nov 11.

9.

Bone loss and aggravated autoimmune arthritis in HLA-DRβ1-bearing humanized mice following oral challenge with Porphyromonas gingivalis.

Sandal I, Karydis A, Luo J, Prislovsky A, Whittington KB, Rosloniec EF, Dong C, Novack DV, Mydel P, Zheng SG, Radic MZ, Brand DD.

Arthritis Res Ther. 2016 Oct 26;18(1):249.

10.

Cytochrome P450 1B1 Contributes to the Development of Angiotensin II-Induced Aortic Aneurysm in Male Apoe(-/-) Mice.

Thirunavukkarasu S, Khan NS, Song CY, Ghafoor HU, Brand DD, Gonzalez FJ, Malik KU.

Am J Pathol. 2016 Aug;186(8):2204-2219. doi: 10.1016/j.ajpath.2016.04.005. Epub 2016 Jun 11.

11.

In Vivo Dual Fluorescence Imaging to Detect Joint Destruction.

Cho H, Bhatti FU, Lee S, Brand DD, Yi AK, Hasty KA.

Artif Organs. 2016 Oct;40(10):1009-1013. doi: 10.1111/aor.12685. Epub 2016 May 16.

PMID:
27183538
12.

6β-Hydroxytestosterone, a Cytochrome P450 1B1-Testosterone-Metabolite, Mediates Angiotensin II-Induced Renal Dysfunction in Male Mice.

Pingili AK, Thirunavukkarasu S, Kara M, Brand DD, Katsurada A, Majid DS, Navar LG, Gonzalez FJ, Malik KU.

Hypertension. 2016 May;67(5):916-26. doi: 10.1161/HYPERTENSIONAHA.115.06936. Epub 2016 Feb 29.

13.

The CII-specific autoimmune T-cell response develops in the presence of FTY720 but is regulated by enhanced Treg cells that inhibit the development of autoimmune arthritis.

Miller DC, Whittington KB, Brand DD, Hasty KA, Rosloniec EF.

Arthritis Res Ther. 2016 Jan 12;18:8. doi: 10.1186/s13075-015-0909-6.

14.

Peptide ligand structure and I-Aq binding avidity influence T cell signaling pathway utilization.

Myers LK, Cullins DL, Park JE, Yi AK, Brand DD, Rosloniec EF, Stuart JM, Kang AH.

Clin Immunol. 2015 Oct;160(2):188-97. doi: 10.1016/j.clim.2015.05.002. Epub 2015 May 14.

15.

Genomic locus on chromosome 1 regulates susceptibility to spontaneous arthritis in mice deficiency of IL-1RA.

Deng N, Jiao Y, Cao Y, Liu X, Ma Y, Hasty KA, Brand DD, Stuart JM, Gu W.

BMC Immunol. 2014 Dec 9;15:57. doi: 10.1186/s12865-014-0057-9.

16.

Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions.

Lu L, Lan Q, Li Z, Zhou X, Gu J, Li Q, Wang J, Chen M, Liu Y, Shen Y, Brand DD, Ryffel B, Horwitz DA, Quismorio FP, Liu Z, Li B, Olsen NJ, Zheng SG.

Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):E3432-40. doi: 10.1073/pnas.1408780111. Epub 2014 Aug 6.

17.

Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis.

Tang B, Kim S, Hammond S, Cullins DL, Brand DD, Rosloniec EF, Stuart JM, Postlethwaite AE, Kang AH, Myers LK.

Arthritis Res Ther. 2014 Jan 10;16(1):R7. doi: 10.1186/ar4433.

18.

Engineered regulatory T cells coexpressing MHC class II:peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis.

Qian Z, Latham KA, Whittington KB, Miller DC, Brand DD, Rosloniec EF.

J Immunol. 2013 Jun 1;190(11):5382-91. doi: 10.4049/jimmunol.1300024. Epub 2013 Apr 29.

19.

Characterisation of freeze-dried type II collagen and chondroitin sulfate scaffolds.

Tamaddon M, Walton RS, Brand DD, Czernuszka JT.

J Mater Sci Mater Med. 2013 May;24(5):1153-65. doi: 10.1007/s10856-013-4882-9. Epub 2013 Feb 8.

PMID:
23392970
20.

Comprehensive mass spectrometric mapping of the hydroxylated amino acid residues of the α1(V) collagen chain.

Yang C, Park AC, Davis NA, Russell JD, Kim B, Brand DD, Lawrence MJ, Ge Y, Westphall MS, Coon JJ, Greenspan DS.

J Biol Chem. 2012 Nov 23;287(48):40598-610. doi: 10.1074/jbc.M112.406850. Epub 2012 Oct 11.

21.

Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.

Kimata M, Cullins DL, Brown ML, Brand DD, Rosloniec EF, Myers LK, Stuart JM, Kang AH.

Arthritis Res Ther. 2012 May 8;14(3):R107. doi: 10.1186/ar3832.

22.

Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis.

Zhou B, Yuan J, Zhou Y, Ghawji M Jr, Deng YP, Lee AJ, Lee AJ, Nair U, Kang AH, Brand DD, Yoo TJ.

Clin Immunol. 2011 Dec;141(3):328-37. doi: 10.1016/j.clim.2011.08.014. Epub 2011 Sep 2.

PMID:
21944669
23.

Nucleosides from Phlebotomus papatasi salivary gland ameliorate murine collagen-induced arthritis by impairing dendritic cell functions.

Carregaro V, Sá-Nunes A, Cunha TM, Grespan R, Oliveira CJ, Lima-Junior DS, Costa DL, Verri WA Jr, Milanezi CM, Pham VM, Brand DD, Valenzuela JG, Silva JS, Ribeiro JM, Cunha FQ.

J Immunol. 2011 Oct 15;187(8):4347-59. doi: 10.4049/jimmunol.1003404. Epub 2011 Sep 19.

24.

T cells stimulated with an analog peptide of type II collagen require the Fc receptor γ-chain to secrete interleukin-4 and suppress autoimmune arthritis in mice.

Myers LK, Cullins DL, Brand DD, Kleinau S, Stuart JM, Kang AH.

Arthritis Rheum. 2011 Sep;63(9):2661-70. doi: 10.1002/art.30454.

25.

Modulation of collagen-induced arthritis by adenovirus-mediated intra-articular expression of modified collagen type II.

Tang B, Cullins DL, Zhou J, Zawaski JA, Park H, Brand DD, Hasty KA, Gaber MW, Stuart JM, Kang AH, Myers LK.

Arthritis Res Ther. 2010;12(4):R136. doi: 10.1186/ar3074. Epub 2010 Jul 8.

26.

Direct visualization of protease action on collagen triple helical structure.

Rosenblum G, Van den Steen PE, Cohen SR, Bitler A, Brand DD, Opdenakker G, Sagi I.

PLoS One. 2010 Jun 16;5(6):e11043. doi: 10.1371/journal.pone.0011043.

27.

An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis.

Qian Z, Latham KA, Whittington KB, Miller DC, Brand DD, Rosloniec EF.

J Immunol. 2010 Jul 1;185(1):110-8. doi: 10.4049/jimmunol.1000416. Epub 2010 May 28.

28.

Inhibition of bleomycin-induced pulmonary fibrosis through pre-treatment with collagen type V.

Braun RK, Martin A, Shah S, Iwashima M, Medina M, Byrne K, Sethupathi P, Wigfield CH, Brand DD, Love RB.

J Heart Lung Transplant. 2010 Aug;29(8):873-80. doi: 10.1016/j.healun.2010.03.012. Epub 2010 May 14.

PMID:
20471860
29.

Isolation of purified and live Foxp3+ regulatory T cells using FACS sorting on scatter plot.

Zhou X, Wang J, Shi W, Brand DD, Liu Z, Fan H, Zheng SG.

J Mol Cell Biol. 2010 Jun;2(3):164-9. doi: 10.1093/jmcb/mjq007. Epub 2010 Apr 29.

30.

Collagen-induced arthritis.

Rosloniec EF, Cremer M, Kang AH, Myers LK, Brand DD.

Curr Protoc Immunol. 2010 Apr;Chapter 15:Unit 15.5.1-25. doi: 10.1002/0471142735.im1505s89.

PMID:
20376842
31.

Inflammasome-independent role of apoptosis-associated speck-like protein containing a CARD (ASC) in T cell priming is critical for collagen-induced arthritis.

Ippagunta SK, Brand DD, Luo J, Boyd KL, Calabrese C, Stienstra R, Van de Veerdonk FL, Netea MG, Joosten LA, Lamkanfi M, Kanneganti TD.

J Biol Chem. 2010 Apr 16;285(16):12454-62. doi: 10.1074/jbc.M109.093252. Epub 2010 Feb 22.

32.

Protein kinase D1 is essential for the proinflammatory response induced by hypersensitivity pneumonitis-causing thermophilic actinomycetes Saccharopolyspora rectivirgula.

Kim YI, Park JE, Brand DD, Fitzpatrick EA, Yi AK.

J Immunol. 2010 Mar 15;184(6):3145-56. doi: 10.4049/jimmunol.0903718. Epub 2010 Feb 8.

33.

Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection.

Braun RK, Molitor-Dart M, Wigfield C, Xiang Z, Fain SB, Jankowska-Gan E, Seroogy CM, Burlingham WJ, Wilkes DS, Brand DD, Torrealba J, Love RB.

Transplantation. 2009 Dec 27;88(12):1341-8. doi: 10.1097/TP.0b013e3181bcde7b.

34.

Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ Treg.

Lu L, Ma J, Wang X, Wang J, Zhang F, Yu J, He G, Xu B, Brand DD, Horwitz DA, Shi W, Zheng SG.

Eur J Immunol. 2010 Jan;40(1):142-52. doi: 10.1002/eji.200939618.

35.

Influence of telopeptides, fibrils and crosslinking on physicochemical properties of type I collagen films.

Walton RS, Brand DD, Czernuszka JT.

J Mater Sci Mater Med. 2010 Feb;21(2):451-61. doi: 10.1007/s10856-009-3910-2. Epub 2009 Oct 23.

PMID:
19851839
36.

Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts.

Yamada Y, Sekine Y, Yoshida S, Yasufuku K, Petrache I, Benson HL, Brand DD, Yoshino I, Wilkes DS.

J Immunol. 2009 Jul 1;183(1):237-45. doi: 10.4049/jimmunol.0804028.

37.

Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies.

Hutamekalin P, Saito T, Yamaki K, Mizutani N, Brand DD, Waritani T, Terato K, Yoshino S.

J Immunol Methods. 2009 Mar 31;343(1):49-55. doi: 10.1016/j.jim.2009.01.009.

PMID:
19330909
38.

Lung transplant ischemia reperfusion injury: metalloprotease inhibition down-regulates exposure of type V collagen, growth-related oncogene-induced neutrophil chemotaxis, and tumor necrosis factor-alpha expression.

Iwata T, Chiyo M, Yoshida S, Smith GN Jr, Mickler EA, Presson R Jr, Fisher AJ, Brand DD, Cummings OW, Wilkes DS.

Transplantation. 2008 Feb 15;85(3):417-26. doi: 10.1097/TP.0b013e31815e91b6.

PMID:
18322435
39.

Silencing S1P1 receptors regulates collagen-V reactive lymphocyte-mediated immunobiology in the transplanted lung.

Chiyo M, Iwata T, Webb TJ, Vasko MR, Thompson EL, Heidler KM, Cummings OW, Yoshida S, Fujisawa T, Brand DD, Wilkes DS.

Am J Transplant. 2008 Mar;8(3):537-46. doi: 10.1111/j.1600-6143.2007.02116.x.

40.

IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.

Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, Bobadilla JL, Meyer KC, Hayney MS, Braun RK, Greenspan DS, Gopalakrishnan B, Cai J, Brand DD, Yoshida S, Cummings OW, Wilkes DS.

J Clin Invest. 2007 Nov;117(11):3498-506.

41.

Collagen-induced arthritis.

Brand DD, Latham KA, Rosloniec EF.

Nat Protoc. 2007;2(5):1269-75.

PMID:
17546023
42.

Cross-linking electrospun type II collagen tissue engineering scaffolds with carbodiimide in ethanol.

Barnes CP, Pemble CW, Brand DD, Simpson DG, Bowlin GL.

Tissue Eng. 2007 Jul;13(7):1593-605.

PMID:
17523878
43.

Metalloproteinase inhibition has differential effects on alloimmunity, autoimmunity, and histopathology in the transplanted lung.

Yoshida S, Iwata T, Chiyo M, Smith GN, Foresman BH, Mickler EA, Heidler KM, Cummings OW, Fujisawa T, Brand DD, Baker A, Wilkes DS.

Transplantation. 2007 Mar 27;83(6):799-808.

PMID:
17414715
44.

Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent.

Srinivasan M, Eri R, Zunt SL, Summerlin DJ, Brand DD, Blum JS.

Arthritis Rheum. 2007 Feb;56(2):498-508.

45.

Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.

Sakurai Y, Brand DD, Tang B, Rosloniec EF, Stuart JM, Kang AH, Myers LK.

Arthritis Res Ther. 2006;8(5):R150.

46.

Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants.

Yoshida S, Haque A, Mizobuchi T, Iwata T, Chiyo M, Webb TJ, Baldridge LA, Heidler KM, Cummings OW, Fujisawa T, Blum JS, Brand DD, Wilkes DS.

Am J Transplant. 2006 Apr;6(4):724-35.

47.

Rodent models of rheumatoid arthritis.

Brand DD.

Comp Med. 2005 Apr;55(2):114-22. Review.

PMID:
15884771
48.

CD80 binding polyproline helical peptide inhibits T cell activation.

Srinivasan M, Lu D, Eri R, Brand DD, Haque A, Blum JS.

J Biol Chem. 2005 Mar 18;280(11):10149-55. Epub 2004 Dec 14.

49.

Pathogenesis of collagen-induced arthritis: modulation of disease by arthritogenic T-cell epitope location.

Tang B, Brand DD, Ma Z, Stuart JM, Myers LK, Kang AH.

Immunology. 2004 Nov;113(3):384-91.

50.

Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis.

Myers LK, Tang B, Brand DD, Rosloniec EF, Stuart JM, Kang AH.

Arthritis Rheum. 2004 Sep;50(9):3004-11.

Supplemental Content

Loading ...
Support Center